ArticleiScience2026
Assessing the health utility values of patients with six common cancers in China using the QLU-C10D: A cross-sectional survey.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to assess health utility values derived from the quality of life utility-core 10 dimensions (QLU-C10D) among 827 Chinese patients with six common cancers and to identify key factors influencing these values. Differences in QLU-C10D utility values across sociodemographic, behavioral, and clinical subgroups were analyzed using the Kruskal-Wallis H test, and key determinants were identified using median regression models. Gastric cancer patients had the highest median utility (0.802), and breast cancer patients had the lowest (0.671). Physical functioning and pain mainly influenced utility, especially in gastric and lung cancer. Economic pressure was most strongly associated with esophageal cancer, while disease stage was most strongly associated with breast cancer. This study assessed utility values in Chinese patients using the Chinese value set, offering key data for cost-utility analyses (CUA).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.